Table of Contents
ISRN Endocrinology
Volume 2012, Article ID 625809, 5 pages
http://dx.doi.org/10.5402/2012/625809
Review Article

The Influence of Incretin Mimetics on Cardiovascular Risk Factors in Diabetes

1Clinic of Endocrinology Diabetology and Internal Medicine, Medical University of Bialystok, M.Curie-Sklodowska 24a, 15-269 Bialystok, Poland
2Clinic of Angiology, Arterial Hypertension and Diebetology, Medical Academy in Wroclaw, ul. Poniatowskiego 2, 50-326 Wrocław, Poland
3Clinic of Ophthalmology, Medical Academy in Wroclaw, ul. Borowska 213, 50-556 Wrocław, Poland
4Novo Nordisk Pharma Sp. z o.o., ul. 17 Stycznia 45B, 02-146 Warszawa, Poland

Received 26 October 2011; Accepted 1 December 2011

Academic Editors: C. Anderwald and A. Hishinuma

Copyright © 2012 Ida Kinalska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ida Kinalska, Dorota Bednarska-Chabowska, Joanna Adamiec-Mroczek, and Lukasz Hak, “The Influence of Incretin Mimetics on Cardiovascular Risk Factors in Diabetes,” ISRN Endocrinology, vol. 2012, Article ID 625809, 5 pages, 2012. https://doi.org/10.5402/2012/625809.